We are live on
!
Find out more
SELLAS Life Sciences
50 hedge funds and large institutions have $5.02M invested in SELLAS Life Sciences in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,190% more call options, than puts
Call options by funds: $1.34M | Put options by funds: $104K
325% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 4
125% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 8
17% more capital invested
Capital invested by funds: $4.27M → $5.02M (+$746K)
14% more funds holding
Funds holding: 44 → 50 (+6)
0% more ownership
Funds ownership: 0.01% → 0.02% (+0%)
Holders
50
Holders Change
+6
Holders Change %
+13.64%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
17
Reduced
4
Closed
8
Calls
$1.34M
Puts
$104K
Net Calls
+$1.24M
Net Calls Change
-$9.01M
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.7M |
| 2 |
Renaissance Technologies
New York
|
+$1.77M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.24M |
| 4 |
BlackRock
New York
|
+$752K |
| 5 |
Goldman Sachs
New York
|
+$227K |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$358K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$34.8K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$34.8K |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$25K |
| 5 |
AS
Arxis Securities
New York
|
-$25K |
